Gufitrig-5000IU HP Combipack Injection 1's

Gufitrig-5000IU HP Combipack Injection 1's belongs to the class of sex hormones used to treat female infertility, male hypogonadism and cryptorchidism. Female infertility is when a woman cannot get pregnant within a year of trying. Male hypogonadism is when the body does not produce enough hormones responsible for masculine growth in men. Cryptorchidism is a condition in which testes don’t descend into the scrotum (bag of skin present below the penis).

Gufitrig-5000IU HP Combipack Injection 1's contains ‘chorionic gonadotrophin’ which stimulates the production of sex hormones such as testosterone in men and progesterone in women. It stimulates ovulation (egg production) in women and improves sperm production in men. Thereby, helps treat female infertility and male hypogonadism.

Gufitrig-5000IU HP Combipack Injection 1's is available in the form of injection. It is usually administered by a healthcare professional. The common side-effects of Gufitrig-5000IU HP Combipack Injection 1's are pain at the injection site, headache, irritability, restlessness, fatigue, oedema (swelling), early puberty and gynecomastia (swelling of breast tissue in men). Most of these side effects do not require medical attention and resolve gradually over time. However, consult your doctor if any of the side effects persist or worsen.

Do not take Gufitrig-5000IU HP Combipack Injection 1's if you are allergic to chorionic gonadotrophin or any other ingredients present in it. It should not be used in patients with conditions such as early puberty, prostatic cancer or other androgen-dependent cancers, unexplained vaginal bleeding, uncontrolled thyroid or adrenal gland dysfunction and ovarian cysts. It is not recommended for use in pregnant women and should be used with caution in breastfeeding mothers.

Gufitrig-5000IU HP Combipack Injection 1's contains ‘chorionic gonadotropin’, which belongs to the ‘sex hormones’ class. It is used to treat female infertility in whom the cause of ovulation problems is a secondary ovarian failure (normal ovaries that don’t function properly). It also helps treat male hypogonadism in conditions where the testes are normal but don’t function properly. Gufitrig-5000IU HP Combipack Injection 1's is also used to treat cryptorchidism in boys from age 4 to 9 if there is no structural deformity. Gufitrig-5000IU HP Combipack Injection 1's stimulates the production of sex hormones such as testosterone in men and progesterone in women. It stimulates ovulation (egg production) in women and improves sperm production in men. Thereby, helps treat female infertility and male hypogonadism.

• Injection site pain
• Headache
• Irritability
• Restlessness
• Depression
• Fatigue
• Oedema (swelling)
• Early puberty
• Gynecomastia (swelling of breast tissue in men)

Avoid taking Gufitrig-5000IU HP Combipack Injection 1's if you are allergic to any of the contents. Inform your doctor if you have early puberty, hormone-related cancer, thyroid or adrenal gland disorder, abnormal vaginal bleeding, ovarian cyst, epilepsy, migraine, asthma, kidney/liver problems, cancer or a tumour of the ovary, breast, uterus, pituitary, prostate, or hypothalamus. Gufitrig-5000IU HP Combipack Injection 1's may cause multiple pregnancies (pregnant with more than one child simultaneously). So, discuss with your doctor the possible risks of this medicine. Inform your doctor if you have a blood disorder as it can increase the risk of blood clots. Early puberty may be seen in children. In such cases, discontinue therapy immediately and consult a doctor. Do not take Gufitrig-5000IU HP Combipack Injection 1's if you are pregnant. Consult your doctor before taking Gufitrig-5000IU HP Combipack Injection 1's if you are breastfeeding.

Drug-drug interactions: Gufitrig-5000IU HP Combipack Injection 1's may have interaction with medicines such as antigonadotropin (ganirelix).

Drug-food interactions: No interactions found.

Drug-disease interactions: Inform your doctor if you have early puberty, androgen-dependent cancers, unexplained vaginal bleeding, uncontrolled thyroid or adrenal gland dysfunction, and ovarian cysts. It should be used with caution in patients with heart or kidney disease, epilepsy (fits), migraine (persistent headache), or asthma (a lung problem).

• GANIRELIX

• Consume a healthy diet that is rich in fibre, proteins and low in carbohydrates, fats.
• Avoid processed or high-sugar foods.
• Stay active and shed excess weight if you are overweight or obese. Do not perform intense exercises as they may negatively impact your reproductive health. Increase the intensity of exercise gradually.
• Being underweight may also affect fertility. So, prepare a diet chart that can help you to gain weight healthily.
• Avoid stress as it may affect your fertility. Try relaxation techniques and receive support and counselling if necessary.
• Limit alcohol and caffeine intake.
• Quit smoking.

• To be sure HCG is helping your condition, your doctor will need to check you on a regular basis. Do not miss any scheduled appointments.
• Some women using this medicine have developed a condition called ovarian hyperstimulation syndrome (OHSS), especially after the first treatment cycle. OHSS can be a life-threatening condition. Call your doctor right away if you have any symptoms of OHSS like severe pelvic pain, swelling of the hands or legs, stomach pain, shortness of breath, weight gain, diarrhoea, nausea or vomiting or if you are urinating less than normal.

Female infertility: It is a condition in which a woman is not able to become pregnant within a year of trying. It could be due to age, hormonal problems, being overweight or underweight, an abnormal menstrual cycle, or other factors.

Male hypogonadism: A condition in which hormones such as testosterone responsible for masculine growth in men are not produced enough in the body. It may cause decreased sexual desire, erectile dysfunction and low sperm production.

Cryptorchidism: It is a condition in which testis fails to descend into the scrotum of boys. It is commonly seen in boys with premature birth and can be easily identified in newborns.